SCHEMBL11174404

SCHEMBL11174404

CC(Cc1ccc(CO)cc1)NCC(O)c1ccc(O)c(CO)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 17/20 0.61
CYP3A4 P08684 4/20 0.56
MAPK1 P28482 4/20 0.56
CYP2D6 P10635 3/20 0.56
TSHR P16473 3/20 0.56
HIF1A Q16665 3/20 0.56
ADRB1 P08588 2/20 0.56
HSD17B10 Q99714 2/20 0.56
CYP1A2 P05177 2/20 0.56
NFKB1 P19838 2/20 0.56
NPSR1 Q6W5P4 2/20 0.56
ADORA3 P0DMS8 1/20 0.56
ADRB3 P13945 1/20 0.56
PTGS1 P23219 1/20 0.56
SLC6A2 P23975 1/20 0.56
HTR2A P28223 1/20 0.56
SLC6A4 P31645 1/20 0.56
MC4R P32245 1/20 0.56
ADRA1A P35348 1/20 0.56
OPRM1 P35372 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7143881 0.91 ADRB2 (0.72) ADRB2CYP2D6TSHRHIF1AADRB1
SCHEMBL13754643 0.91 ADRB2 (0.72) ADRB2CYP2D6TSHRHIF1AADRB1
SCHEMBL7143882 0.91 ADRB2 (0.72) ADRB2CYP2D6TSHRHIF1AADRB1
SCHEMBL11180151 0.89 ADRB2 (0.56) ADRB2CYP3A4MAPK1CYP2D6TSHR
Salmefamol SCHEMBL20285629 0.89 ADRB2 (0.67) ADRB2CYP3A4MAPK1CYP2D6TSHR
Salmefamol SCHEMBL30361710 0.89 ADRB2 (0.67) ADRB2CYP3A4MAPK1CYP2D6TSHR
Salmefamol SCHEMBL18458 0.89 ADRB2 (0.67) ADRB2CYP3A4MAPK1CYP2D6TSHR
SCHEMBL9661334 0.88 ADRB2 (0.69) ADRB2CYP3A4MAPK1CYP2D6TSHR
SCHEMBL10662533 0.87 ADRB2 (0.63) ADRB2CYP3A4MAPK1CYP2D6TSHR
SCHEMBL10661718 0.87 ADRB2 (0.63) ADRB2CYP3A4MAPK1CYP2D6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4396627-A HYPOGLYCEMIC AGENTS, TREATMENT OF OBECITY BEECHAM GROUP LIMITED (GB) 1983-08-02 US disclosed
EP-0021636-B1 SECONDARY AMINES, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS BEECHAM GROUP PLC (GB) 1982-12-01 EP disclosed
EP-0021636-A1 Secondary amines, their preparation and use in pharmaceutical compositions BEECHAM GROUP PLC (GB) 1981-01-07 EP disclosed